Jeffrey Wolf Says Submitted Preliminary Non-Binding Offer Letter To Board Of Nighthawk

T-Reuters
Aug 21, 2023

NightHawk Biosciences Inc :Jeffrey Wolf - On August 18, Submitted Preliminary Non-Binding Offer Letter To Board Of Nighthawk Biosciences Inc For Starlight.Jeffrey Wolf - Offer Letter To Acquire All Equity Interest Of Nighthawk Biosciences’ Unit, Elusys Therapeutics, Inc. And Its On-Going Operations.Jeffrey Wolf-Offer Letter To Acquire All Intellectual Property Related To Early-Stage Biodefense,Research Assets Currently Being Developed By Nighthawk.Jeffrey Wolf- May Respond To Inquiries From Nighthawk And Board Or Their Representatives And Engage In Discussions And Negotiations.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10